A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study | Zendy

Iñaki Izquierdo | Zendy; Agache | Zendy; Kowalski | Zendy; Rivas | Zendy; Roger Roger | Zendy; Ulrich Botzen | Zendy; KarlFriedrich Lukat | Zendy; Francoise Sanquer | Zendy; F. Wessel | Zendy

Open Access

A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study

Author(s) -

Iñaki Izquierdo,

Agache,

Kowalski,

Rivas,

Roger Roger,

Ulrich Botzen,

KarlFriedrich Lukat,

Francoise Sanquer,

F. Wessel

Publication year - 2013

Publication title -

journal of asthma and allergy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.162

H-Index - 30

ISSN - 1178-6965

DOI - 10.2147/jaa.s39496

Subject(s) - medicine , desloratadine , rhinorrhea , placebo , randomized controlled trial , nasal congestion , adverse effect , anesthesia , nose , surgery , alternative medicine , pathology , pharmacology

H1-antihistamines are recommended as the first-line symptomatic treatment of allergic rhinitis. The objective of this study was to evaluate the effects of rupatadine (RUP) versus desloratadine (DES) in subjects with seasonal allergic rhinitis (SAR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research